Muscat: Johnson & Johnson booster dose provides strong response against COVID-19.
Johnson & Johnson released data showing that a booster dose provides a strong immune response, months after people receive the first dose.
Johnson & Johnson said in a statement that it ran two early studies in people who were given its vaccine and found that a second dose produced an increased antibody response in adults from age 18 to 55. The study’s results have not yet been peer-reviewed.
The company is in talks with regulators including the US Food and Drug Administration, the European Medicines Agency and others regarding using booster doses of its vaccine, the Associated Press (AP) news reported.